Back to Results
First PageMeta Content



Articles Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Add to Reading List

Document Date: 2014-10-18 21:24:32


Open Document

File Size: 367,04 KB

Share Result on Facebook